| Absorption |
| Blood-Brain Barrier | BBB- | 0.9659 |
| Human Intestinal Absorption | HIA- | 0.7692 |
| Caco-2 Permeability | Caco2- | 0.7205 |
| P-glycoprotein Substrate | Non-substrate | 0.5185 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9298 |
| Non-inhibitor | 0.9165 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8919 |
| Distribution |
| Subcellular localization | Mitochondria | 0.3356 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8676 |
| CYP450 2D6 Substrate | Non-substrate | 0.8203 |
| CYP450 3A4 Substrate | Non-substrate | 0.5821 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.7603 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8303 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.8940 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.8044 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8436 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9530 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9878 |
| Non-inhibitor | 0.8964 |
| AMES Toxicity | Non AMES toxic | 0.6686 |
| Carcinogens | Non-carcinogens | 0.8339 |
| Fish Toxicity | High FHMT | 0.9576 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.8645 |
| Honey Bee Toxicity | Low HBT | 0.6599 |
| Biodegradation | Not ready biodegradable | 0.9925 |
| Acute Oral Toxicity | IV | 0.6131 |
| Carcinogenicity (Three-class) | Non-required | 0.5233 |